163 related articles for article (PubMed ID: 29246570)
21. Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.
Mou X; Wu Y; Cao H; Meng Q; Wang Q; Sun C; Hu S; Ma Y; Zhang H
Stem Cell Res Ther; 2012 Apr; 3(2):14. PubMed ID: 22512921
[TBL] [Abstract][Full Text] [Related]
22. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
23. Generation of spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cell line SCA3.A11.
Hansen SK; Borland H; Hasholt LF; Tümer Z; Nielsen JE; Rasmussen MA; Nielsen TT; Stummann TC; Fog K; Hyttel P
Stem Cell Res; 2016 May; 16(3):553-6. PubMed ID: 27346190
[TBL] [Abstract][Full Text] [Related]
24. Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.
Vazquez-Martin A; Vellon L; Quirós PM; Cufí S; Ruiz de Galarreta E; Oliveras-Ferraros C; Martin AG; Martin-Castillo B; López-Otín C; Menendez JA
Cell Cycle; 2012 Mar; 11(5):974-89. PubMed ID: 22333578
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Efficiency of Viral Transduction and Episomal Transfection in Human Fibroblast Reprogramming.
Vdovin AS; Lupatov AY; Kholodenko IV; Yarygin KN
Bull Exp Biol Med; 2015 Nov; 160(1):123-8. PubMed ID: 26593412
[TBL] [Abstract][Full Text] [Related]
26. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
27. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
28. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
29. Porcine induced pluripotent stem cells produce chimeric offspring.
West FD; Terlouw SL; Kwon DJ; Mumaw JL; Dhara SK; Hasneen K; Dobrinsky JR; Stice SL
Stem Cells Dev; 2010 Aug; 19(8):1211-20. PubMed ID: 20380514
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
31. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
[TBL] [Abstract][Full Text] [Related]
32. Episomal Induced Pluripotent Stem Cells: Functional and Potential Therapeutic Applications.
Wang AYL; Loh CYY
Cell Transplant; 2019 Dec; 28(1_suppl):112S-131S. PubMed ID: 31722555
[TBL] [Abstract][Full Text] [Related]
33. Generation of human iPS cell line IBCHi001-A from dentatorubral-pallidoluysian atrophy patient's fibroblasts.
Kozlowska E; Ciolak A; Olejniczak M; Fiszer A
Stem Cell Res; 2019 Aug; 39():101512. PubMed ID: 31374462
[TBL] [Abstract][Full Text] [Related]
34. Successful Derivation of an Induced Pluripotent Stem Cell Line from a Genetically Nonpermissive Enhanced Green Fluorescent Protein-Transgenic FVB/N Mouse Strain.
Abbey D; Singh G; Verma I; Derebail S; Kolkundkar U; Chandrashekar DS; Acharya KK; Vemuri MC; Seshagiri PB
Cell Reprogram; 2019 Oct; 21(5):270-284. PubMed ID: 31596624
[TBL] [Abstract][Full Text] [Related]
35. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
Liu C; Ameen M; Himmati S; Thomas D; Sayed N
Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
[TBL] [Abstract][Full Text] [Related]
36. Derivation, characterization and retinal differentiation of induced pluripotent stem cells.
Mekala SR; Vauhini V; Nagarajan U; Maddileti S; Gaddipati S; Mariappan I
J Biosci; 2013 Mar; 38(1):123-34. PubMed ID: 23385820
[TBL] [Abstract][Full Text] [Related]
37. Induced pluripotent stem cells generated from human adipose-derived stem cells using a non-viral polycistronic plasmid in feeder-free conditions.
Qu X; Liu T; Song K; Li X; Ge D
PLoS One; 2012; 7(10):e48161. PubMed ID: 23110200
[TBL] [Abstract][Full Text] [Related]
38. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin.
Yan X; Qin H; Qu C; Tuan RS; Shi S; Huang GT
Stem Cells Dev; 2010 Apr; 19(4):469-80. PubMed ID: 19795982
[TBL] [Abstract][Full Text] [Related]
39. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
40. Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.
Xia G; Santostefano K; Hamazaki T; Liu J; Subramony SH; Terada N; Ashizawa T
J Mol Neurosci; 2013 Oct; 51(2):237-48. PubMed ID: 23224816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
